New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Olanzapine Treatment
- 1 September 1999
- journal article
- case report
- Published by Elsevier in Psychosomatics
- Vol. 40 (5) , 438-443
- https://doi.org/10.1016/s0033-3182(99)71210-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Body Weight and Leptin Plasma Levels During Treatment With Antipsychotic DrugsAmerican Journal of Psychiatry, 1999
- Novel antipsychotics and new onset diabetesBiological Psychiatry, 1998
- Clozapine and body mass changeBiological Psychiatry, 1998
- Clozapine and Associated Diabetes MellitusThe Journal of Clinical Psychiatry, 1997
- Obesity and endocrine disorders in women taking valproate for epilepsyAnnals of Neurology, 1996
- Ketoacidosis as a side‐effect of clozapine: a case reportActa Psychiatrica Scandinavica, 1996
- Weight Gain Associated With Neuroleptic Medication: A ReviewSchizophrenia Bulletin, 1995
- Clozapine-related PancreatitisAnnals of Internal Medicine, 1994
- Acute pancreatitis associated with clozapine useAmerican Journal of Psychiatry, 1992
- Clozapine-induced weight gain: prevalence and clinical relevanceAmerican Journal of Psychiatry, 1992